BNP Paribas Asset Management’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CAM
CCM
BNP Paribas Asset Management's LMAT Position: Q2 2026 in Review
BNP Paribas Asset Management increased its LeMaitre Vascular (LMAT) stake by 2,443% in Q2 2026, buying an estimated $361K and bringing the position to 3,662 shares worth $351K. The position accounts for ﹤0.01% of the portfolio, ranked #1338.
BNP Paribas Asset Management first reported a position in LMAT in Q2 2025 and has held it in 5 quarters since. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.
- BNP Paribas Asset Management held 3,662 shares of LeMaitre Vascular worth $351K as of Q2 2026.
- BNP Paribas Asset Management bought 3,518 LeMaitre Vascular shares in Q2 2026, an estimated $361K.
- LeMaitre Vascular made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #1338 holding.
- BNP Paribas Asset Management first reported a position in LeMaitre Vascular in Q2 2025 and has held it in 5 quarters since.
- 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.
Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.